Valuation GSK plc

Stocks

Market Closed - London S.E. Other stock markets 11:35:03 2026-06-12 am EDT			5-day change	1st Jan Change
1,984.00 ^GBX	+1.10%		+4.31%	+8.74%

12:09pm	European Stocks Close Higher; German Inflation Cools, UK GDP Contracts	MT
05:43am	GSK's Clonal Myeloid Disorder Treatment Gets Orphan Drug Designation From US, European Regulators	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	78,342	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	7.02%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	92,594	89,531	87,186
Change	-	-24.65%	-1.89%	-8.24%	28.83%	5.64%	-3.31%	-2.62%
P/E Ratio	18.6x	3.93x	11.9x	21.3x	12.9x	12.6x	11.7x	11.4x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.66x	3.84x	3.26x
PEG	-	0x	-0.2x	-0.4x	0x	1.2x	1.47x	4.41x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.32x	2.21x	2.14x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.74x	2.52x	2.38x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.06x	7.29x	6.96x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.09x	8.16x	7.63x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.5x	14.8x	13.8x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.04%	6.74%	7.23%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.7006	0.7328	0.763
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.57%	3.73%	3.89%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.558	1.682	1.725
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	45%	43.6%	44.2%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,783	35,477	36,579
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,481	12,281	12,525
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,181	10,967	11,432
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,266	6,669	6,902
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	14,252	11,189	8,844
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.62	19.62	19.62
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,991,951	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	12.64x	2.74x	8.06x	3.56%	105B
ELI LILLY AND COMPANY	33.97x	12.34x	25.42x	0.59%	1,035B
JOHNSON & JOHNSON	25.47x	5.87x	15.96x	2.24%	574B
ABBVIE INC.	27.52x	6.71x	13.7x	3.05%	397B
ROCHE HOLDING AG	17.45x	4.31x	10.59x	3.08%	324B
ASTRAZENECA PLC	22.84x	4.75x	13.5x	1.84%	281B
NOVARTIS AG	21.11x	5.44x	13.22x	2.98%	278B
NOVO NORDISK A/S	12.49x	4.69x	9.58x	4.02%	193B
AMGEN INC.	23.02x	6.15x	10.74x	2.85%	191B
GILEAD SCIENCES, INC.	-45.04x	5.44x	30.73x	2.58%	156B
Average	15.15x	5.84x	15.15x	2.68%	353.45B
Weighted average by Cap.	22.56x	7.43x	17.36x	2.14%